Immunostep
1 known investors
Find your way into Immunostep
ImmunoStep produces monoclonal antibodies for research use, including recombinant antibodies that target specific T-cell receptors for flow cytometry applications in immunology research.
Investors · 1
In the news
Frequently asked questions
- What does Immunostep do?
- ImmunoStep produces monoclonal antibodies for research use, including recombinant antibodies that target specific T-cell receptors for flow cytometry applications in immunology research.
- Who are Immunostep's investors?
- Immunostep's investors include Unirisco Galicia.